Code | 9397D | ||||||||||
MA number | 16/0003/22-S | ||||||||||
Product Form: | sol inj 10x5 ml/500 mg (amp.skl.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Mutual recognition procedure | ||||||||||
MAH, country: | MEDOCHEMIE Ltd., Cyprus | ||||||||||
Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | glass ampoule | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 19.01.2022 |
Validity: | 19.01.2027 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
SPC: |
|
PIL: |
|
Safety feature | Yes |
Data update: | 21.01.2022 |